INS and primary biliary cholangitis: Moreover, by targeting PPAR-δ, Seladelpar may exert additional beneficial effects on lipid metabolism, insulin sensitivity, and inflammatory pathways, which are dysregulated in PBC and contribute to disease pathogenesis.